Stock Events

Stock Events

Silence Therapeutics (SLNCF) Q2 2024 Earnings

16MayConfirmed

Q4 2023

Q2 2024

-0.05

-0.04

-0.02

-0.01

Details

Expected EPS

-0.0403203866

Actual EPS

-0.0058911541

Surprise EPS

0.03

Surprise Percent

+85.39%

Description

Silence Therapeutics (SLNCF) has reported earnings of -0.0058911541 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.